ARCpoint Inc
ARC
Minas Metals Ltd
MINA
Quri-Mayu Developments Ltd
QURI
KGL Resources Ltd
KGL.H
Alerio Gold Corp
ALE
CA Stock MarketDetailed Quotes
HBP Helix BioPharma Corp
- 1.000
- +0.130+14.94%
15min DelayMarket Closed Dec 13 16:00 ET
49.02MMarket Cap-0.95P/E (TTM)
1.000High1.000Low25.07KVolume1.000Open0.870Pre Close25.07KTurnover1.35052wk High0.06%Turnover Ratio49.02MShares0.50052wk Low-1.05EPS TTM44.04MFloat Cap40.250Historical HighLossP/E (Static)44.04MShs Float0.300Historical Low-1.05EPS LYR0.00%Amplitude--Dividend TTM-500.00P/B1Lot Size--Div YieldTTM
Helix BioPharma Corp Key Stats
Quarterly+Annual
YOY
| (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | (Q2)Jan 31, 2023 | (Q1)Oct 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 46.05%9.24M | 145.89%5.26M | 34.44%1.82M | -27.02%902K | -21.01%1.25M | 4.74%6.33M | 91.93%2.14M | 4.15%1.36M | -35.83%1.24M | -6.54%1.59M |
| Selling and administrative expenses | 212.15%3.26M | 754.80%2.4M | 24.26%338K | 5.80%219K | 6.32%303K | -30.15%1.05M | 1.08%281K | -25.07%272K | -50.71%207K | -36.24%285K |
| -General and administrative expense | 212.15%3.26M | 754.80%2.4M | 24.26%338K | 5.80%219K | 6.32%303K | -30.15%1.05M | 1.08%281K | -25.07%272K | -50.71%207K | -36.24%285K |
| Research and development costs | 13.18%5.98M | 53.85%2.86M | 36.99%1.49M | -33.62%683K | -27.00%949K | 16.22%5.28M | 122.10%1.86M | 15.44%1.08M | -31.67%1.03M | 4.08%1.3M |
| Operating profit | -46.05%-9.24M | -145.89%-5.26M | -34.44%-1.82M | 27.02%-902K | 21.01%-1.25M | -4.74%-6.33M | -91.93%-2.14M | -4.15%-1.36M | 35.83%-1.24M | 6.54%-1.59M |
| Net non-operating interest income (expenses) | -27.27%24K | 200.00%9K | 0 | -135.71%-5K | 66.67%10K | 335.71%33K | 400.00%3K | 600.00%10K | 255.56%14K | 300.00%6K |
| Non-operating interest income | -34.04%31K | 66.67%10K | -85.71%2K | 0.00%17K | 30.00%13K | 1,075.00%47K | 50.00%6K | --14K | --17K | --10K |
| Non-operating interest expense | -50.00%7K | -66.67%1K | -50.00%2K | 633.33%22K | -25.00%3K | -22.22%14K | -40.00%3K | 100.00%4K | -66.67%3K | 33.33%4K |
| Other net income (expenses) | -1,733.33%-49K | -47.06%-25K | -188.89%-8K | -86.49%5K | 53.85%-12K | 100.59%3K | 93.73%-17K | 121.95%9K | 144.05%37K | 77.19%-26K |
| Gain on sale of security | -2,350.00%-49K | -47.06%-25K | -300.00%-8K | -86.49%5K | 53.85%-12K | 77.78%-2K | -666.67%-17K | -63.64%4K | 242.31%37K | -966.67%-26K |
| Special income (charges) | --0 | --0 | --0 | ---- | ---- | --5K | --0 | --5K | ---- | ---- |
| -Gain on sale of property,plant,equipment | --0 | --0 | --0 | ---- | ---- | --5K | --0 | --5K | ---- | ---- |
| Income before tax | -47.28%-9.26M | -145.03%-5.28M | -36.95%-1.83M | 23.88%-902K | 21.87%-1.25M | 4.17%-6.29M | -55.30%-2.15M | 0.59%-1.34M | 41.31%-1.19M | 11.47%-1.61M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -47.28%-9.26M | -145.03%-5.28M | -36.95%-1.83M | 23.88%-902K | 21.87%-1.25M | 4.16%-6.29M | -55.41%-2.15M | 0.59%-1.34M | 41.31%-1.19M | 11.47%-1.61M |
| Net income continuous operations | -47.28%-9.26M | -145.03%-5.28M | -36.95%-1.83M | 23.88%-902K | 21.87%-1.25M | 4.16%-6.29M | -55.41%-2.15M | 0.59%-1.34M | 41.31%-1.19M | 11.47%-1.61M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -47.28%-9.26M | -145.03%-5.28M | -36.95%-1.83M | 23.88%-902K | 21.92%-1.25M | 4.16%-6.29M | -55.41%-2.15M | 0.59%-1.34M | 41.31%-1.19M | 11.42%-1.61M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -47.28%-9.26M | -145.03%-5.28M | -36.95%-1.83M | 23.88%-902K | 21.92%-1.25M | 4.16%-6.29M | -55.41%-2.15M | 0.59%-1.34M | 41.31%-1.19M | 11.42%-1.61M |
| Diluted earnings per share | -31.25%-1.05 | -99.96%-0.1077 | 14.10%-0.043 | 57.02%-0.0215 | 0.00%-0.05 | -300.00%-0.8 | -0.0538 | 0.00%-0.05 | 0.00%-0.05 | 0.00%-0.05 |
| Basic earnings per share | -31.25%-1.05 | -99.96%-0.1077 | 14.10%-0.043 | 57.02%-0.0215 | 0.00%-0.05 | -300.00%-0.8 | -0.0538 | 0.00%-0.05 | 0.00%-0.05 | 0.00%-0.05 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.